Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Renal Impairment Study With ASP1941

This study has been completed.
Information provided by (Responsible Party):
Astellas Pharma Inc Identifier:
First received: February 21, 2011
Last updated: June 5, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2010
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):